Skip to search boxSkip to navigationSkip to main content

Stimulus properties of dopaminergic drugs: comparisons involving selective agonists and antagonists.

  • J. B. Appel(corresponding author)
    ,
  • R. T. Weathersby
    ,
  • K. A. Cunningham
    ,
  • P. M. Callahan
    ,
  • R. L. Barrett
*Corresponding author for this work
  • University of South Carolina
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

Rats were trained to discriminate the putatively selective dopamine (DA) receptor agonists SKF 38393 (10 mg/kg) or Ly 171555 (0.025 mg/kg) from saline in a two-lever situation involving fixed-ratio (FR 20), extinction schedules of water reinforcement. During substitution tests, no dose of any compound [apomorphine, Ly 171555, lisuride, LSD, amphetamine, cocaine, (-) 3-PPP, or SKF 82526] mimicked SKF 38393, the effects of which were blocked by the D1 antagonist Sch 23390 but not by haloperidol. Postsynaptic and DA "autoreceptor" agonists [apomorphine, (-) 3-PPP], as well as dopaminergic ergot derivatives (bromocriptine, lergotrile, lisuride) and Sch 23390, substituted for Ly 171555, a partial ergoline which has behavioral effects that are blocked by haloperidol and molindone, but not by either Sch 23390 or serotonin (5-HT) antagonists (ketanserin, pizotifen). Amphetamine and cocaine did not substitute for either SKF 38393 or Ly 171555. These results suggest that the stimulus properties of a variety of neuropharmacologically important and clinically useful compounds are transduced at (pre- or postsynaptic) D2 receptors. However, this conclusion must be tempered by evidence that actions at D1 and D2 receptors may not be entirely independent. The behavioral effects of abused psychomotor stimulants probably involve mechanisms other than "direct" agonist activity at either D1 or D2 receptors.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 44-56 (13 pages)

Journal (Volume, Issue Number)

Psychopharmacology series (Volume 4)

Publication milestones

  • Published - 1988

Publication status

Published - 1988

ISSN

0931-6795

Publication IDs

  • Scopus: 0023763948
  • PubMed: 3293045

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
4
Citation count
15

Funding Details

FunderFunding number
NIDA
R01DA002543